Clinical Trial Update: A Phase 2 RCT Study of CX-8998 for Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 randomized trial of CX-8998 for essential tremor has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• CX-8998

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2021-10-22